# Medtronic to acquire CathWorks for up to USD 585 million

Medtronic announced it will exercise its option to acquire CathWorks, a medical device company, for up to USD 585 million. The deal follows a 2022 strategic partnership and aims to bolster Medtronic's interventional cardiology portfolio.

- Type: Acquisition
- Announced: 2026-02-03
- Where: Israel
- Value: $585.0M
- Status: announced
- Products: FFRangio System for coronary artery disease diagnosis
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Medtronic plc](https://endata.com/companies/19071.md) (acquirer)
- [CathWorks](https://endata.com/companies/64068.md) (target)

## Sources

- [news.medtronic.com](https://news.medtronic.com/2026-02-03-Medtronic-advances-its-innovation-strategy-with-intent-to-acquire-CathWorks), 2026-02-03: "Medtronic today announced it will exercise its option to acquire CathWorks, a privately held medical device company, which aims to transform how coronary artery disease (CAD) is diagnosed and treated."
- [fiercebiotech.com](https://www.fiercebiotech.com/medtech/medtronic-steps-half-billion-deal-israeli-devicemaker-cathworks), 2026-02-04: "This acquisition allows Medtronic to transform the cath lab with a technology that provides real-time data, informs individualized treatment approaches, and drives new standards of care."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.